Vimarsana
Biggest News Aggregation in the World

Patient Stratification News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patient Stratification. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patient Stratification Today - Breaking & Trending Today

Chronic fatigue syndrome: number of patients is expected to double due to long-term effects of the COVID-19 pandemic - Vimarsana News

Chronic fatigue syndrome: number of patients is expected to double due to long-term effects of the COVID-19 pandemic

Up to 80,000 people in Austria are estimated to suffer from chronic fatigue syndrome, also known as ME/CFS or myalgic encephalomyelitis/chronic fatigu....

Corticosteroids and Clinical Trial Design in Chronic GVHD - Vimarsana News

Corticosteroids and Clinical Trial Design in Chronic GVHD

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz discuss the complexities of chronic GVHD management, highlighting recent developments and efforts to reduce reliance on steroids.

New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other Indications via Non-Invasive Imaging - Vimarsana News

New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other Indications via Non-Invasive Imaging

New Data Opens Potential for Patient Stratification for CriPec® Nanomedicines in Cancer and Other Indications via Non-Invasive ImagingMaastricht, The Netherlands, 4 May 2022 – Cristal Therapeutics, a Dutch pharmaceutical company developing tailored nanomedicines for the treatment of cancer and other d...

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022 - Vimarsana News

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

/PRNewswire/ -- QurAlis Corporation, a biotech company developing breakthrough precision medicines for amyotrophic lateral sclerosis (ALS) and other...

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022 - Vimarsana News

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022

QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022 - read this article along with other careers information, tips and advice on BioSpace